Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy.

@article{Jensen1996TreatmentWA,
  title={Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy.},
  author={Benny Vittrup Jensen and Steen Levin Nielsen and Torben Skovsgaard},
  journal={Lancet},
  year={1996},
  volume={347 8997},
  pages={297-9}
}
BACKGROUND Anthracycline chemotherapy in cancer can cause severe, frequently fatal congestive heart failure (CHF), the first-line treatment for which is diuretics and digoxin. We have studied the use of an angiotensin-converting-enzyme (ACE) inhibitor added as a third agent. METHODS In an observational study in hospital and as outpatients, 92 patients… CONTINUE READING